NIH awards OHSU scientists, collaborators $8.4 million to develop a cure for HIV
Only a handful of people in history have been cured of the virus; three have agreed to kick off landmark research project led by OHSU.
Research
More Research Stories
- Latest Stories
Unintended pregnancy rates higher among women with disabilities, study says
February 27, 2020
Societal views of pregnancy and parenting may create barriers to reproductive education, health services.
Adults don’t need tetanus, diphtheria boosters if fully vaccinated as children, study finds
February 25, 2020
U.S. currently recommends booster shots for adults every 10 years.
Tim and Mary Boyle give $10 million to OHSU for joint center for biomedical data science
February 20, 2020
Donation supports new Oregon-based collaboration utilizing “big data” to better fight cancer and other diseases.
Investigational blood test could detect many types of cancer with one blood draw
February 18, 2020
OHSU tapped to join new early detection study; men and women aged 50 and older may be eligible to participate.
Cancer genome study reveals big window for early detection
February 05, 2020
New findings suggest that it will be possible to find and treat many cancers early.
HIV patients lose smallpox immunity despite childhood vaccination, AIDS drugs
January 28, 2020
HIV-associated immune amnesia could explain why HIV-positive people still have shorter lives than HIV-negative counterparts.
Three OHSU scientists earn $2.25 million to accelerate innovation, collaboration
January 23, 2020
Inaugural Faculty Excellence Awards will fund research in marijuana use in pregnancy, new therapies for heart disease, leukemia.
Single dose of antibodies can knock out HIV in newborns
January 07, 2020
Study: Combination of 2 antibodies taken 30 hours after virus exposure prevents infection in baby monkeys.
Study: Hearing develops in tandem with form and function
January 02, 2020
Mouse model insight could focus future hearing loss reversal research on early development.
Cases of NTM lung infection increase by nearly 8%, study says
December 27, 2019
Respiratory complications due to nontuberculous mycobacteria most likely to impact females, people older than 65.